{
    "nct_id": "NCT05069597",
    "official_title": "A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis or Chronic Pancreatitis Treated With CreonÂ® (Pancrelipase) With an Alternate Source of Active Pharmaceutical Ingredient",
    "inclusion_criteria": "* Previous diagnosis of cystic fibrosis (CF) or chronic pancreatitis (CP).\n* Previous diagnosis of exocrine pancreatic insufficiency (EPI) that is currently clinically controlled.\n* Total Symptom Score (TSS) < 1.8 on Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) at Screening.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "- Malignancy involving the digestive tract in the last 5 years, or other significant disease or medical condition that may interfere with EPI symptom assessment.",
    "miscellaneous_criteria": ""
}